OPTIMUM INVESTMENT ADVISORS - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
OPTIMUM INVESTMENT ADVISORS ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$22,000
+83.3%
1000.0%0.01%
+50.0%
Q4 2020$12,000
+20.0%
1000.0%0.00%
+33.3%
Q3 2020$10,000
-16.7%
1000.0%0.00%
-25.0%
Q2 2020$12,000
+33.3%
1000.0%0.00%0.0%
Q1 2020$9,000
-10.0%
1000.0%0.00%
+33.3%
Q4 2019$10,000
-80.8%
100
-66.7%
0.00%
-78.6%
Q3 2018$52,000
+4.0%
300
-45.5%
0.01%
-12.5%
Q1 2015$50,000
+35.1%
5500.0%0.02%
+33.3%
Q4 2014$37,0005500.01%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders